"neuroendocrine tumor" trang 7 - tải miễn phí từ tailieunhanh
A prospective, randomized, phase II study to assess the schemas of retreatment with Lutathera® in patients with new progression of an intestinal, well-differentiated neuroendocrine tumor (ReLUTH)

A prospective, randomized, phase II study to assess the schemas of retreatment with Lutathera® in patients with new progression of an intestinal, well-differentiated neuroendocrine tumor (ReLUTH)
6    1    1
Exosome-derived lnc-HOXB8-1:2 induces tumor-associated macrophage infltration to promote neuroendocrine differentiated colorectal cancer progression by sponging hsa-miR-6825-5p

Exosome-derived lnc-HOXB8-1:2 induces tumor-associated macrophage infltration to promote neuroendocrine differentiated colorectal cancer progression by sponging hsa-miR-6825-5p
17    17    1
Paravertebral paraganglioma with spinal extension: A case report

Paravertebral paraganglioma with spinal extension: A case report
9    12    1
Severe hypercalcemia due to metastatic pancreatic neuroendocrine tumor: A case report

Severe hypercalcemia due to metastatic pancreatic neuroendocrine tumor: A case report
8    13    1
Evaluation of the safety and immunological effects of Bacillus Calmette–Guérin in combination with checkpoint inhibitor therapy in a patient with neuroendocrine carcinoma: A case report

Evaluation of the safety and immunological effects of Bacillus Calmette–Guérin in combination with checkpoint inhibitor therapy in a patient with neuroendocrine carcinoma: A case report
7    21    1
Life-threatening diarrhea in neuroendocrine tumors: Two case reports

Life-threatening diarrhea in neuroendocrine tumors: Two case reports
6    20    1
Single-cell transcriptomic analysis reveals tumor cell heterogeneity and immune microenvironment features of pituitary neuroendocrine tumors

Single-cell transcriptomic analysis reveals tumor cell heterogeneity and immune microenvironment features of pituitary neuroendocrine tumors
17    12    1
Báo cáo y học:

Báo cáo y học: "Fast-growing pancreatic neuroendocrine carcinoma in a patient with multiple endocrine neoplasia type 1: a case report"
7    36    0
CARCINOGENESIS, DIAGNOSIS, AND MOLECULAR TARGETED TREATMENT FOR NASOPHARYNGEAL CARCINOMA

CARCINOGENESIS, DIAGNOSIS, AND MOLECULAR TARGETED TREATMENT FOR NASOPHARYNGEAL CARCINOMA

256    81    0
The Cost of Delay State Dental Policies Fail One in Five Children

The Cost of Delay State Dental Policies Fail One in Five Children
74    76    0
Eating well for older people: Practical and nutritional guidelines for food in residential and nursing homes and for community meals

Eating well for older people: Practical and nutritional guidelines for food in residential and nursing homes and for community meals
78    79    0
MESOTHELIOMAS – YNONYMS AND DEFINITION, EPIDEMIOLOGY, ETIOLOGY, PATHOGENESIS, CYTO-HISTOPATHOLOGICAL ATURES, CLINIC, DIAGNOSIS, TREATMENT, PROGNOSIS

MESOTHELIOMAS – YNONYMS AND DEFINITION, EPIDEMIOLOGY, ETIOLOGY, PATHOGENESIS, CYTO-HISTOPATHOLOGICAL ATURES, CLINIC, DIAGNOSIS, TREATMENT, PROGNOSIS

256    84    0
GLOBAL CONCERNS: IMPLICATIONS FOR THE FUTURE

GLOBAL CONCERNS: IMPLICATIONS FOR THE FUTURE

52    83    0
In Partnership with the Government of Kenya 2011-2014

In Partnership with the Government of Kenya 2011-2014

31    38    0
Prostate cancer - Diagnosis and treatment

Prostate cancer - Diagnosis and treatment

41    87    0
Sách: Early and locally advanced breast cancer - Diagnosis and treatment

Sách: Early and locally advanced breast cancer - Diagnosis and treatment

37    79    0
The World Health Report 2008 - Primary Health Care

The World Health Report 2008 - Primary Health Care
148    83    0
NEUROENDOCRINOLOGY AND BEHAVIOR

NEUROENDOCRINOLOGY AND BEHAVIOR
172    55    0
First Principles of Project Management By R. Max Wideman

First Principles of Project Management By R. Max Wideman
10    69    0
Social Marketing: A Resource Guide from the Social Marketing National Excellence Collaborative

Social Marketing: A Resource Guide from the Social Marketing National Excellence Collaborative
94    57    0